Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Gains from Investment Securities (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Gains from Investment Securities for 3 consecutive years, with -$16000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gains from Investment Securities rose 99.15% year-over-year to -$16000.0, compared with a TTM value of -$109000.0 through Sep 2025, down 107.11%, and an annual FY2024 reading of $8817.0, down 37.22% over the prior year.
  • Gains from Investment Securities was -$16000.0 for Q2 2025 at SeaStar Medical Holding, roughly flat from -$16000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.8 million in Q1 2024 and bottomed at -$1.9 million in Q2 2024.
  • Average Gains from Investment Securities over 3 years is -$35900.0, with a median of -$56500.0 recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 8005.56% in 2024, while the deepest fall reached 160.03% in 2024.
  • Year by year, Gains from Investment Securities stood at $760000.0 in 2023, then tumbled by 110.13% to -$77000.0 in 2024, then soared by 79.22% to -$16000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for ICU at -$16000.0 in Q2 2025, -$16000.0 in Q1 2025, and -$77000.0 in Q4 2024.